PAREXEL International Corp. (NASDAQ:PRXL) updated its FY14 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $2.01-2.11 for the period, compared to the Thomson Reuters consensus estimate of $2.05, American Banking & Market News reports. The company issued revenue guidance of $1.92-1.93 billion, compared to the consensus revenue estimate of $1.93 billion.PAREXEL International Corp. also updated its Q3 guidance to $0.52-0.54 EPS.
PRXL has been the subject of a number of recent research reports. Analysts at ISI Group upgraded shares of PAREXEL International Corp. from a buy rating to a strong-buy rating in a research note to investors on Wednesday, January 22nd. They now have a $56.00 price target on the stock, up previously from $53.00. On a related note, analysts at Thomson Reuters/Verus downgraded shares of PAREXEL International Corp. from a buy rating to a hold rating in a research note to investors on Monday, January 20th. Finally, analysts at Thomson Reuters/Verus upgraded shares of PAREXEL International Corp. from a hold rating to a buy rating in a research note to investors on Tuesday, December 24th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, four have given a buy rating and two have issued a strong buy rating to the stock. PAREXEL International Corp. presently has an average rating of Buy and a consensus target price of $51.51.
PAREXEL International Corp. (NASDAQ:PRXL) opened at 48.03 on Thursday. PAREXEL International Corp. has a 52-week low of $32.75 and a 52-week high of $55.02. The stock has a 50-day moving average of $45. and a 200-day moving average of $47.2. The company has a market cap of $2.714 billion and a price-to-earnings ratio of 26.65.
PAREXEL International Corp. (NASDAQ:PRXL) last issued its quarterly earnings data on Thursday, January 30th. The company reported $0.49 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.49. The company had revenue of $487.10 million for the quarter, compared to the consensus estimate of $479.49 million. During the same quarter in the prior year, the company posted $0.41 earnings per share. The company’s quarterly revenue was up 15.4% on a year-over-year basis. On average, analysts predict that PAREXEL International Corp. will post $2.03 earnings per share for the current fiscal year.
PAREXEL International Corporation (NASDAQ:PRXL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.